Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants

American Journal of Perinatology

Volumn 24, Issue 6, 2007, Pages 339-345

  Cherif, Ahmed ^a   Jabnoun, Sami ^a   Khrouf, Naima ^a  

^a Centre de Maternite et de Neonatologie Tunis   (Tunisia)

Author keywords

Ductus arteriosus; Oral ibuprofen; Premature infant

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CIMETIDINE; DOPAMINE; FUROSEMIDE; GLUCOCORTICOID; IBUPHIL; IBUPROFEN; LUNG SURFACTANT; NITRIC OXIDE; PORACTANT; UNCLASSIFIED DRUG;

ABDOMEN; ARTICLE; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; COLOR ULTRASOUND FLOWMETRY; CREATININE BLOOD LEVEL; DEATH; DRUG EFFICACY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ECHOENCEPHALOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFANT; INTESTINE PERFORATION; KIDNEY DISEASE; LEUKOMALACIA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFUSIONS, INTRAVENOUS; MALE; TREATMENT OUTCOME;

EID: 34447288484     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981853     Document Type: Article

References (22)

1. The Vermont-Oxford Trials Network. Very low birth weight outcomes for 1990. Pediatrics 1993;91:540-545
2. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978;93:647-651
3. Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. Eur J Pediatr 1999;158:484-487
4. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906
5. Van Bel F, Guit GL, Schipper J, van de Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991;118:621-626
6. Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990;165:1067-1071
7. Mardoum R, Bejar R, Merritt A, Berry C. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. J Pediatr 1991;118:112-115
8. Van Overmeire B, Smets K, Lecoutere D, van de Broek H, Weyler J. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-681
9. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-140
10. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics 2003;112:e354-e358
11. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-534
12. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992;49:1-6
13. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg 1978;187:1-7
14. Hariprasad P, Sundarrajan V, Srimathy G, Suthagar B, Ramadevi BS. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr 2002;39:99-100
15. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002;85(Suppl 4):S1252-S1258
16. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003;86(Suppl 3):S563-S569
17. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906
18. Raju NV, Bharadwaj RA, Thomas R, Konduri GG. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. J Perinatol 2000;20:13-16
19. Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr 2004;93:999-1001
20. Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 2003;43:968-973
21. Van Overmeire B, Touw D, Schepens PJC, Kearns GL, van den Anker J. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001;70:336-343
22. Achour W, Abbassi MS, Cherif A, Jabnoun S, Khrouf N, Ben Hassen A. Nosocomial respiratory infection due to an imipenem-resistant Pseudomonas aeruginosa O: 12 strain in a Tunis's neonatal intensive care unit. Pathol Biol 2006;54:596-599